Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ADGRB2	BAI2	ENSG00000121753	"Adhesion G protein-coupled receptor B2"	O60241	1	31727117-31764893	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 52.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 20.5;SH-SY5Y: 15.0;T-47d: 17.3;U-2 OS: 16.9"	"Cancer enhanced"	"Detected in many"		"glioma: 20.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052612, HPA054617"			Enhanced	Centrosome			49000	Centrosome		"HPA052612: , HPA054617: "	"prognostic favourable (6.46e-4)"	"unprognostic (1.74e-1)"	"unprognostic (7.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-4)"	"prognostic unfavourable (4.02e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.75e-3)"	"unprognostic (7.98e-2)"	2.2	5.4	15.9	1.3	26.8	1.1	1.4	7.9	52.0	2.4	1.4	7.3	0.0	5.2	2.4	1.2	1.6	2.2	2.1	2.8	18.9	8.0	1.4	0.9	1.3	1.3	7.4	16.5	1.8	1.4	1.3	2.7	3.8	8.4	2.4	1.1	1.3	1.4	3.1	1.1	1.5	5.0	2.4	2.9	1.8	1.8	3.2	6.3	1.5	3.2	0.0	1.1	2.0	0.5	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.5	4.4	4.1	11.9	1.2	0.7	2.0	2.8	4.5	2.7	4.9	0.2	1.3	0.0	2.8	1.2	0.4	1.8	0.2	0.4	3.1	1.8	0.0	20.5	0.0	0.1	0.0	1.5	0.7	0.3	3.8	0.0	0.4	0.4	0.1	3.0	0.4	7.8	0.1	5.1	1.3	11.9	0.4	0.4	0.0	5.6	3.1	15.0	6.4	0.4	0.5	17.3	0.0	0.1	2.1	16.9	0.3	0.7	0.0	0.0	0.4	6.6	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	15.9	26.8	7.9	37.6	18.9	8.0	7.4	16.5	8.4	6.3
ALMS1	KIAA0328	ENSG00000116127	"ALMS1, centrosome and basal body associated protein"		2	73385758-73610793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 23.2"	"Cell line enhanced"	"Detected in all"		"RH-30: 23.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035276, HPA035277, HPA043200"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Centrosome, Cytosol"	Nucleoplasm	"HPA035276: , HPA035277: , HPA043200: AB_10796689"	"unprognostic (2.86e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.91e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.58e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	3.4	1.7	3.0	6.5	5.5	6.3	3.9	5.5	4.5	6.0	4.0	5.4	4.3	2.0	7.4	3.9	2.2	7.9	4.3	1.6	3.4		3.5	2.1	2.7	2.5	2.0	5.0	11.0	4.0	6.1	6.6	3.2	3.6	3.6	3.3	4.7	2.3	5.8	2.3	1.8	2.4	4.2	3.2	2.1	2.8	23.2	3.4	6.7	5.1	1.9	3.2	2.9	4.1	0.8	1.3	1.3	0.4	0.5	1.2	0.0	8.4	3.3	6.2	4.5	2.4	4.0	3.9	2.9	3.2	4.8	3.6	3.7	1.1	7.9	1.8	4.8	3.7	10.4	3.2	7.2	4.7	2.9	5.3	3.7	2.9	2.1	7.3	2.6	3.1	1.9	6.6	3.3	4.2	5.9	4.2	4.0	2.5	6.9	3.3	8.0	3.1	7.7	23.8	3.3	1.2	3.0	5.1	6.0	6.6	1.1	2.7	1.4	1.8	2.6	6.7	7.0	5.3	6.9	4.9	2.5	8.5	2.5	4.2	3.0	0.0	0.1	1.3	1.2	0.2	0.3	0.2	0.6	0.1	0.1	0.8	0.4	0.6	0.0	0.5	0.4	1.3	0.1	0.0										
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			740000	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: , HPA067561: "	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	25.8	20.4	32.7	32.0	40.1	46.0	28.2	50.7	33.7	24.5	30.7	40.5	16.0	27.0	26.8	21.7	28.8	30.0	23.4	47.8	32.3	23.6	30.0	29.6	27.2	55.0	33.9	30.0	26.7	25.6	24.2	18.3	38.6	26.6	30.4	35.4	27.2	23.6	27.8	41.7	18.9	28.9	30.5	42.7	40.1	29.8	9.4	36.7	75.0	29.0	18.5	52.4	35.7	27.6	12.7	19.8	27.7	19.9	18.1	12.3	9.6	26.0	32.0	42.1	36.3	14.8	13.0	28.0	13.7	18.5	27.0	22.8	26.4	49.1	84.6	25.8	15.5	38.3	97.4	28.1	32.5	38.1	33.1	64.0	27.1	33.0	9.2	50.3	34.6	10.4	19.9	14.8	29.6	39.2	46.5	33.1	23.1	18.2	50.5	41.3	37.4	16.2	70.9	39.1	50.2	23.8	41.2	55.9	34.7	20.9	23.6	38.7	31.4	66.0	17.5	28.0	44.6	19.3	36.7	20.1	55.7	98.0	18.6	84.7	25.6	8.1	17.6	27.7	11.9	19.9	10.0	12.7	9.8	12.3	19.8	12.7	12.1	10.6	18.1	18.1	16.8	17.6	11.2	9.6	32.7	40.1	50.7	33.7	32.3	23.6	33.9	30.0	26.6	36.7
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983361-98015943	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			290000	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: , HPA067561: , HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	43.0	24.6	37.9	46.5	55.5	105.7	37.7	15.6	30.1	43.2	38.9	81.0	24.6	32.7	46.3	38.4	40.4	28.4	39.2	27.0	41.8	32.0	26.0	35.9	35.0	70.4	55.7	21.7	51.1	46.0	29.3	20.7	37.5	41.8	38.9	42.3	26.2	32.5	29.7	29.4	38.6	34.9	45.3	88.3	38.6	36.7	19.0	47.6	85.9	37.0	31.9	81.8	64.5	58.6	34.8	32.6	36.8	44.6	22.7	51.3	25.1	70.9	38.4	42.8	35.7	24.1	42.7	39.0	36.9	32.7	39.7	33.5	48.1	34.9	87.1	22.1	24.7	47.0	57.7	41.6	45.6	56.5	32.5	75.3	33.0	51.9	31.0	129.1	43.9	32.3	30.5	31.8	65.8	34.4	144.9	61.7	30.5	94.8	97.4	114.8	16.7	38.2	58.2	66.8	41.4	25.9	29.8	34.6	30.2	43.3	42.3	37.8	23.9	48.3	41.7	25.9	42.0	32.5	38.7	56.0	63.2	52.6	24.0	51.8	48.2	23.1	27.2	36.8	22.7	30.9	31.3	34.8	42.7	31.9	32.6	29.6	51.3	38.7	11.3	22.7	44.6	31.8	50.8	25.1	37.9	55.5	15.6	30.1	41.8	32.0	55.7	21.7	41.8	47.6
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472665-48473624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.3;REH: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: , HPA067561: "		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.1	0.9	0.3	0.0	0.2	0.1	0.2	0.2	0.6	0.0	0.5			0.0	0.6	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.7	0.0	0.2		1.1	0.1	0.0	0.2	0.5		0.3	0.2		0.4	0.3	0.2	0.0	0.1	0.2	0.2	0.5	0.2	0.9			0.8		0.0	0.4	0.1	0.1	0.1	0.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.4	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0										
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			18000	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: , HPA067561: "	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	11.5	18.3	31.2	21.0	30.9	38.4	10.6	50.3	20.6	14.3	11.3	18.3	13.5	12.9	16.5	21.0	12.8	12.8	11.9	19.8	22.9	25.9	18.6	16.8	13.3	38.4	26.5	19.5	19.1	6.9	20.1	14.7	12.3	21.2	14.2	10.9	20.1	9.2	20.9	25.5	12.5	14.5	25.2	32.7	20.3	9.9	6.0	17.8	52.2	18.1	13.6	34.7	20.6	12.1	24.5	8.2	20.7	10.5	14.6	27.0	15.7	33.7	21.9	45.7	22.7	3.6	5.3	17.4	18.2	10.3	17.6	16.9	16.1	24.0	61.6	16.2	10.4	11.8	25.7	11.3	25.3	70.5	15.6	42.7	27.2	23.2	3.4	85.6	21.7	4.3	1.8	16.4	15.2	13.0	40.8	36.5	16.1	35.1	34.9	22.3	46.1	10.0	37.2	25.4	32.4	12.5	13.6	15.0	25.8	38.0	6.1	10.7	16.5	43.8	13.4	9.0	25.5	9.3	36.4	47.2	47.3	60.4	10.3	61.9	16.4	20.7	10.5	16.3	18.0	7.3	27.0	24.5	24.2	19.7	8.2	17.0	17.4	21.6	7.2	14.6	8.8	5.7	25.7	15.7	31.2	30.9	50.3	20.6	22.9	25.9	26.5	19.5	21.2	17.8
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 62.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: , HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.1	0.4	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3
CCDC14	"DKFZp434L1050, FLJ12892"	ENSG00000175455	"Coiled-coil domain containing 14"	Q49A88	3	123897305-123961408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035278, HPA035279"	Uncertain		Enhanced	Centrosome				Centrosome		"HPA035278: , HPA035279: AB_10601253"	"unprognostic (7.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.45e-2)"	"prognostic favourable (5.27e-4)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (6.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavourable (4.76e-4)"	"prognostic unfavourable (3.50e-8)"	"unprognostic (2.14e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.37e-2)"	"prognostic favourable (2.72e-5)"	11.3	9.7	13.6	22.4	15.2	30.0	19.1	8.0	16.2	14.5	18.8	10.8	7.7	12.0	20.4	31.9	10.2	15.8	14.9	9.1	13.6	8.7	13.3	13.7	14.1	14.3	14.3	13.0	20.6	15.4	7.8	24.4	9.7	14.5	17.2	31.8	9.6	14.3	9.8	5.9	20.2	15.9	13.6	17.4	13.7	12.8	22.5	16.0	36.5	14.0	11.2	13.3	12.7	13.0	2.1	4.5	3.0	2.2	6.0	5.6	1.9	16.5	9.7	30.1	11.9	4.2	6.2	14.1	33.4	11.0	16.2	18.7	7.6	11.9	4.9	8.6	6.9	18.9	10.9	5.5	22.0	4.1	7.7	19.7	17.9	7.1	3.9	12.9	12.7	6.2	3.5	8.4	9.0	7.7	10.2	9.1	11.1	8.2	11.2	6.1	9.0	11.4	19.3	12.5	5.6	9.3	13.6	10.5	12.5	19.6	4.9	12.7	11.7	9.5	10.0	39.2	20.4	12.0	10.8	8.6	6.0	14.8	13.2	9.9	13.6	2.8	1.6	3.0	3.9	2.2	2.6	2.1	3.4	3.3	1.0	2.0	3.8	3.2	0.3	6.0	0.6	4.5	5.6	1.9	13.6	15.2	8.0	16.2	13.6	8.7	14.3	13.0	14.5	16.0
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"				Centrosome	"Cell Junctions"	"CAB079753: , HPA035820: AB_10671939, HPA046529: "	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.8	23.3	14.0	10.1	14.9	12.5	12.3	9.5	14.0	13.1	13.2	12.6	17.8	5.7	12.0	21.0	18.4	14.1	13.5	14.2	7.4	15.2	30.8	23.3	9.5	18.7	10.2	26.8	9.4	12.4	16.4	12.1	14.0	15.5	18.3	21.5	20.0	12.0	21.6	12.7	19.7	27.9	8.4	10.0	7.6	15.3	17.6	21.4	11.8	14.2	27.6	12.9	8.1	12.2	13.3	14.2	13.9	11.3	15.7	20.0	12.7	12.0	25.5	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413268	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606, HPA061504"	Uncertain		Enhanced	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA037605: AB_10672908, HPA037606: AB_10672498, HPA061504: "	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.1	6.8	7.8	11.2	10.4	7.0	7.2	17.4	7.8	10.5	6.8	9.1	11.2	4.7	17.4	9.4	9.7	12.9	12.1	4.6	6.9	6.8	7.1	7.2	7.3	7.7	7.4	8.3	13.9	28.1	10.8	19.1	5.1	8.2	7.4	5.8	16.4	6.9	7.6	3.1	8.3	6.2	11.5	10.4	9.7	6.3	29.7	8.3	10.8	9.6	5.0	14.4	8.0	8.0	18.0	21.1	36.5	16.6	11.8	21.4	4.3	8.8	12.4	9.1	18.2	9.2	15.8	2.9	17.7	9.9	12.7	12.5	15.3	14.5	17.6	12.8	10.9	11.8	10.1	10.4	10.9	17.4	8.4	5.3	12.2	4.8	13.6	7.6	11.9	10.9	8.9	19.3	18.8	16.4	14.4	11.6	9.9	7.7	7.0	6.9	6.5	13.5	9.4	10.9	6.9	5.6	7.7	10.7	15.5	14.0	8.6	10.1	11.8	8.9	17.7	15.2	9.5	14.6	16.1	4.1	5.0	10.5	7.4	8.7	10.0	30.7	15.7	9.4	15.9	12.9	10.1	15.2	20.0	17.9	5.8	18.0	18.9	15.1	36.5	11.8	16.6	21.1	21.4	4.3	7.8	10.4	17.4	7.8	6.9	6.8	7.4	8.3	8.2	8.3
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.7"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Enhanced	"Mitotic spindle,Centrosome,Cytosol"				Centrosome	"Mitotic spindle, Cytosol"	"HPA042151: , HPA045597: , HPA045787: "	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavourable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	9.5	6.1	13.7	10.8	13.2	36.5	6.8	27.7	23.2	7.4	5.4	11.4	3.1	3.1	9.1	5.2	5.5	6.4	11.1	8.6	12.8	11.2	3.8	6.7	8.4	7.3	19.3	13.7	13.3	2.8	2.8	10.8	9.8	20.2	5.0	4.2	3.3	4.2	5.5	9.3	4.2	4.7	7.4	25.8	7.8	4.2	53.7	18.0	11.6	14.4	3.3	8.9	8.6	6.6	9.4	8.4	12.3	10.1	2.8	4.7	2.1	6.0	5.1	13.1	11.1	8.2	15.9	2.8	16.1	9.5	12.1	11.4	3.1	5.9	4.5	9.8	13.6	3.0	11.3	6.9	17.2	10.0	6.5	4.6	4.8	2.2	7.1	8.2	8.8	10.0	1.9	38.5	16.9	28.1	11.3	4.7	15.3	1.3	5.0	4.3	16.5	14.5	9.0	9.4	1.5	2.5	1.0	19.0	25.7	8.2	0.7	7.7	2.8	11.1	31.1	22.6	6.7	12.1	18.4	4.6	5.9	9.0	12.0	7.5	51.8	3.5	8.3	7.6	1.9	10.0	2.7	3.6	3.8	1.6	8.4	9.4	4.7	2.7	12.3	2.8	10.1	5.5	2.9	2.1	13.7	13.2	27.7	15.8	12.8	11.2	19.3	13.7	20.2	18.0
CEP350	"CAP350, KIAA0480"	ENSG00000135837	"Centrosomal protein 350"	Q5VT06	1	179954738-180114880	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028355, HPA028357, HPA030845, CAB079754"	Enhanced		Enhanced	Centrosome				Centrosome		"CAB079754: , HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: "	"unprognostic (9.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.84e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (4.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.13e-1)"	17.2	11.3	13.8	18.9	18.0	26.5	14.0	23.1	14.8	15.3	16.9	13.1	10.5	11.1	13.9	11.9	13.4	11.9	10.8	12.8	13.1	9.4	11.4	12.6	12.4	16.9	17.7	12.3	18.0	13.7	27.2	25.5	14.4	16.2	11.6	13.9	9.0	13.5	12.1	44.2	15.1	22.1	11.5	14.6	17.8	13.4	28.8	18.5	29.8	13.9	11.6	16.5	17.0	20.1	7.2	5.9	8.1	3.7	3.2	6.1	1.3	12.7	9.3	12.0	4.2	10.2	9.5	11.2	8.7	11.7	7.5	8.3	10.3	7.7	14.2	9.5	7.8	15.8	9.0	5.0	9.9	13.7	6.2	10.1	11.7	6.4	11.2	19.9	9.5	9.4	7.9	9.8	12.9	9.2	19.5	10.8	8.1	9.4	11.6	5.6	11.2	2.3	10.1	13.2	10.9	5.3	26.7	8.4	9.0	14.5	9.8	16.6	10.6	17.9	9.3	10.7	7.5	9.4	9.2	18.9	23.8	27.8	5.0	8.6	15.9	2.3	3.7	8.1	5.4	3.4	6.1	4.1	3.9	3.4	3.0	7.2	4.2	3.5	7.3	3.2	3.0	5.9	5.7	1.3	13.8	18.0	23.1	14.8	13.1	9.4	17.7	12.3	16.2	18.5
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Enhanced	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: "	"unprognostic (7.46e-2)"	"prognostic favourable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	15.9	15.5	18.0	14.0	1.8	1.3	13.7	15.3	7.4	19.6	16.5	27.4	16.5	29.4	15.5	6.8	12.0	8.7	8.1	8.8	8.8	12.5	24.0	23.1	15.9	0.1	11.2	15.2	1.0	0.5	10.7	1.9	5.0	6.3	20.8	12.1	14.1	23.8	23.8	5.4	22.3	23.8	49.1	12.1	3.3	9.8	26.9	18.9	18.6	13.0	7.6	16.3	14.2	2.7	22.9	13.4	15.8	21.7	20.3	13.7	24.2	19.0	6.7	13.5	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491945	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.5;testis: 16.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol				Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: , HPA043926: , HPA061524: "	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (5.52e-4)"	"prognostic unfavourable (1.93e-7)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	1.6	1.4	0.6	13.4	0.6	11.4	2.4	0.4	0.9	1.7	5.0	0.6	0.6	4.5	0.6	2.3	6.4	0.5	0.9	1.6	0.8	0.7	1.4	1.8	2.5	10.9	1.0	0.4	0.6	1.1	0.6	0.5	6.9	1.1	0.7	5.6	0.4	1.6	0.2	1.4	2.3	4.8	1.4	1.9	8.6	2.6	16.7	0.3	54.5	0.7	5.6	10.8	1.8	2.1	1.2	1.8	0.6	0.7	1.5	4.8	0.8	21.1	13.3	27.1	14.5	1.4	2.6	20.2	20.1	9.8	25.2	22.9	27.0	40.8	35.1	19.2	6.2	24.4	31.3	19.0	43.0	31.8	9.7	21.0	9.5	13.1	0.4	18.6	19.4	0.7	1.1	23.6	18.5	14.3	19.8	28.8	26.2	7.7	19.6	10.6	23.4	14.5	21.4	36.3	17.6	9.8	5.7	22.7	12.6	29.9	9.4	11.4	27.6	14.9	9.3	18.1	15.3	14.4	26.9	15.5	25.9	28.3	11.9	28.8	17.3	0.5	0.7	0.0	0.5	0.3	0.9	1.2	1.0	0.6	0.9	0.9	0.4	0.7	0.6	1.5	0.0	1.8	4.8	0.8	0.6	0.6	0.4	0.9	0.8	0.7	1.0	0.4	1.1	0.3
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520643-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 16.1;U-937: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"				Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: , HPA013335: AB_1847553, HPA030747: "	"unprognostic (2.03e-1)"	"prognostic favourable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favourable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favourable (2.94e-4)"	4.2	9.8	5.5	10.6	6.7	15.4	5.4	22.6	6.1	8.4	7.8	7.4	3.8	3.6	7.8	4.6	6.4	8.6	6.6	5.9	4.8	3.2	4.4	1.7	5.6	15.6	6.8	6.2	11.5	2.9	3.7	11.5	4.5	6.5	6.5	10.0	5.3	18.2	7.9	1.5	8.3	9.3	5.4	4.9	13.3	4.5	9.7	10.4	17.8	4.6	2.8	15.0	8.6	7.5	5.5	3.6	2.2	2.7	2.7	9.0	4.0	0.1	0.0	6.1	7.1	1.8	2.1	0.0	1.5	3.2	1.8	5.5	0.5	2.6	6.1	5.2	1.3	4.5	6.8	2.0	1.3	4.5	2.5	5.0	0.5	0.0	1.6	5.2	0.4	2.7	2.0	2.1	2.0	2.3	3.2	9.6	1.3	4.4	5.1	16.1	2.8	2.5	4.2	2.1	4.9	1.4	2.5	1.0	2.2	2.0	2.1	0.2	2.2	9.8	1.2	4.7	2.7	0.0	1.7	11.1	8.7	9.0	1.5	15.0	0.9	0.0	2.5	2.2	5.1	2.2	6.1	5.5	5.8	5.9	3.6	4.9	9.0	5.8	1.6	2.7	2.7	3.5	3.1	4.0	5.5	6.7	22.6	6.1	4.8	3.2	6.8	6.2	6.5	10.4
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578148-6640927	"Disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023057, HPA023494"	Enhanced		Enhanced	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	6.5	7.0	7.5	11.7	12.8	4.5	9.9	7.4	9.4	10.1	7.7	7.3	20.1	4.4	17.8	15.6	8.5	13.4	10.7	5.0	8.3	7.7	8.7	4.3	8.3	6.6	4.9	7.9	15.4	10.5	26.4	26.0	7.4	8.0	9.6	9.2	9.6	7.0	13.6	5.4	7.4	6.4	11.5	7.2	9.0	7.9	20.1	5.1	13.7	12.1	4.1	6.8	8.4	7.7	2.3	1.8	5.5	2.2	1.1	2.0	0.7	15.6	12.1	15.8	11.0	6.0	10.4	6.0	8.5	8.0	12.1	10.6	8.9	3.6	5.6	5.7	7.8	14.6	14.9	7.7	19.4	5.6	11.9	3.2	10.5	6.3	8.9	5.5	7.2	6.8	10.9	12.1	10.0	8.8	7.9	0.8	9.4	5.5	6.0	4.8	9.6	6.4	8.8	5.3	1.8	10.8	10.2	5.9	10.6	11.2	2.9	6.5	5.0	3.6	8.1	11.4	5.2	5.9	12.5	1.3	1.9	2.4	8.0	3.2	7.6	0.0	2.0	1.7	1.8	2.2	2.0	2.3	1.5	1.6	1.3	1.4	1.2	1.1	5.5	1.1	1.1	1.8	1.1	0.7	7.5	12.8	7.4	9.4	8.3	7.7	4.9	7.9	8.0	5.1
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62537249	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome			2100000	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: , HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (5.45e-4)"	"prognostic unfavourable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.3	9.3	25.4	21.9	26.4	12.4	15.5	15.4	40.1	19.7	13.5	19.4	8.0	10.3	12.9	7.6	14.3	17.5	13.7	7.2	26.2	24.1	8.2	5.8	10.6	29.4	24.9	24.6	13.0	12.3	15.2	14.3	27.8	37.0	10.2	14.5	6.8	10.7	11.9	7.4	7.9	15.8	13.5	34.3	17.4	9.6	39.2	26.4	28.7	13.0	5.6	26.7	17.4	14.8	9.0	8.4	7.1	3.0	15.8	25.4	9.7	17.2	17.3	28.9	25.6	10.9	15.4	23.6	18.5	15.3	20.2	25.6	18.6	18.9	42.8	20.4	16.3	11.0	21.9	14.9	27.0	42.9	15.3	43.0	16.2	10.1	12.9	23.4	16.4	12.7	9.8	19.6	17.8	18.4	30.4	26.1	16.8	13.0	39.1	11.6	16.8	10.9	28.9	22.9	23.6	9.0	21.0	25.9	21.5	25.1	10.6	13.0	13.8	13.2	15.9	12.0	19.9	13.9	18.4	24.7	35.6	45.2	13.9	28.2	14.7	7.1	3.0	3.4	20.2	2.6	22.8	9.0	20.3	20.6	4.0	7.8	17.9	18.4	5.3	15.8	1.8	8.4	25.4	9.7	25.4	26.4	15.4	31.2	26.2	24.1	24.9	24.6	37.0	26.4
MAP7D3	FLJ12649	ENSG00000129680	"MAP7 domain containing 3"	Q8IWC1	X	136213220-136256482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA035598, HPA058101"	Approved		Enhanced	Centrosome				Centrosome		"HPA035598: AB_10671108, HPA058101: "	"unprognostic (2.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavourable (9.00e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (4.16e-5)"	"unprognostic (5.35e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (7.91e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (5.38e-5)"	26.1	4.8	2.9	9.3	3.8	4.5	21.2	0.9	2.2	14.3	9.0	1.7	6.8	2.2	11.4	12.3	10.6	13.7	6.7	17.7	2.7	1.9	9.9	6.5	6.9	6.4	4.1	1.1	23.6	2.8	8.3	14.1	32.6	5.5	9.4	3.5	4.6	3.8	8.6	27.9	5.3	6.2	15.3	6.5	11.8	6.5	16.0	3.1	9.5	9.6	10.2	4.9	13.9	14.6	9.8	6.2	5.9	9.2	8.4	9.3	3.9	15.4	5.5	4.2	7.2	9.5	10.0	5.8	15.0	8.3	12.3	17.0	5.5	7.8	8.0	24.3	13.1	7.5	12.2	8.0	16.9	7.3	12.2	4.8	8.8	0.0	10.5	11.8	5.0	20.3	4.6	12.6	15.7	9.6	4.1	12.7	9.1	9.8	13.9	4.5	5.9	0.1	13.8	11.4	4.0	0.4	2.4	3.0	6.3	8.7	3.3	5.4	0.0	5.4	28.5	13.2	7.6	16.7	19.0	8.6	10.3	9.2	9.0	19.8	6.2	5.9	4.8	1.4	7.5	5.5	9.3	9.8	7.1	8.2	5.8	8.5	7.6	6.0	1.0	8.4	9.2	6.2	5.0	3.9	2.9	3.8	0.9	2.2	2.7	1.9	4.1	1.1	5.5	3.1
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA005939: , HPA070691: "	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	13.0	6.1	15.1	24.9	10.3	34.8	9.7	12.6	14.0	8.0	9.2	7.6	4.5	5.0	11.8	6.1	11.8	8.2	7.6	16.4	11.7	4.9	6.7	5.2	10.7	30.2	7.6	10.0	11.0	5.4	9.1	12.3	20.2	7.1	6.5	7.7	6.2	8.2	5.1	16.9	10.9	8.3	12.0	7.1	18.2	9.3	4.6	9.0	16.4	7.8	5.1	25.8	11.7	10.3	6.8	6.3	18.4	2.3	1.5	6.0	1.3	12.2	8.7	18.1	15.4	7.0	11.2	7.6	10.5	9.1	8.9	7.5	5.6	6.5	28.8	7.2	14.1	12.9	14.5	6.6	18.7	13.9	4.5	10.6	5.3	5.3	4.1	18.4	30.6	7.7	5.3	15.5	6.4	14.1	2.6	11.8	13.4	13.4	13.9	7.4	2.5	9.6	15.8	33.5	2.0	8.0	13.9	8.4	9.5	13.2	4.0	11.3	7.5	16.4	20.5	22.6	31.4	8.6	11.6	9.5	4.8	19.9	5.9	15.0	12.2	12.6	2.3	18.4	3.3	1.7	3.5	6.8	2.2	6.0	1.5	5.5	4.4	3.8	8.3	1.5	1.5	6.3	1.9	1.3	15.1	10.3	12.6	14.0	11.7	4.9	7.6	10.0	7.1	9.0
NLRC5	"CLR16.1, FLJ21709, NOD27"	ENSG00000140853	"NLR family CARD domain containing 5"	Q86WI3	16	56989485-57083531	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 40.7;NB-4: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA059120, HPA060405"			Enhanced	Centrosome				Centrosome		"HPA059120: , HPA060405: "	"unprognostic (9.66e-2)"	"prognostic favourable (9.69e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.24e-2)"	"prognostic favourable (2.30e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.75e-3)"	10.0	5.7	3.4	26.4	7.0	24.9	6.0	1.6	6.2	5.4	7.0	4.2	2.9	4.9	10.8	4.4	6.4	4.9	8.9	3.7	4.3	2.4	5.5	5.5	12.8	21.3	7.0	2.0	3.9	3.6	2.1	20.2	2.3	6.0	5.2	5.6	4.7	8.9	3.0	3.5	10.9	16.1	5.8	7.8	24.6	7.2	1.3	6.3	9.4	5.9	6.6	29.7	7.3	7.0	5.4	1.7	13.2	4.0	2.7	7.0	2.7	4.8	0.9	0.1	0.3	0.3	1.6	0.0	2.7	4.2	8.6	8.4	0.0	8.4	9.9	2.0	4.4	3.2	1.1	0.3	1.0	0.4	0.3	40.7	8.6	0.9	3.0	1.4	2.4	3.2	0.1	7.0	0.7	3.3	0.0	2.0	1.8	0.1	2.2	22.3	0.0	0.9	10.6	3.1	4.1	0.9	0.4	0.3	0.3	5.4	0.5	1.1	0.6	5.3	4.2	4.1	1.4	15.1	2.2	4.0	2.1	10.1	7.4	3.0	0.7	6.4	4.0	13.2	7.0	2.2	4.2	5.4	4.0	6.6	1.7	3.1	2.6	2.7	9.8	2.7	2.5	1.3	4.6	2.7	3.4	7.0	1.6	6.2	4.3	2.4	7.0	2.0	6.0	6.3
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18029944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Enhanced	"Nuclear membrane,Centrosome,Cytosol"				Centrosome	"Nuclear membrane, Cytosol"	"CAB058695: , HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	19.6	19.0	26.2	26.7	40.4	25.1	25.1	29.2	29.0	25.0	21.1	21.6	22.8	12.4	23.3	27.3	16.4	26.4	17.8	23.0	22.9	18.4	18.8	22.0	19.1	21.1	24.5	24.9	29.1	27.0	42.0	35.8	19.8	26.4	20.2	16.3	16.2	19.4	25.3	63.1	17.6	18.3	26.7	27.2	20.8	17.9	80.0	28.0	40.2	28.2	19.1	20.4	27.0	22.6	11.5	14.9	19.9	7.5	11.2	13.0	4.3	20.3	21.7	33.4	44.2	18.9	19.7	17.3	17.2	21.2	18.4	20.8	14.7	12.2	26.7	11.9	17.1	14.8	21.3	15.8	31.4	8.8	8.2	45.8	15.4	29.8	21.1	20.0	11.8	17.1	16.9	21.3	23.7	21.1	30.9	20.8	22.4	10.2	42.9	33.2	27.5	6.3	25.9	29.9	9.5	15.2	28.3	25.6	19.3	18.4	10.1	26.4	15.9	29.3	18.8	16.8	13.7	20.5	14.5	8.9	19.6	23.9	14.2	22.1	17.1	19.9	6.0	14.4	11.5	3.8	12.0	11.1	10.4	13.0	5.9	11.5	11.6	11.6	6.4	11.2	7.5	14.9	10.3	4.3	26.2	40.4	29.2	29.0	22.9	18.4	24.5	24.9	26.4	28.0
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324122-46445769	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 82.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 10.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7"	"Low region specificity"	"Detected in all"							"HPA016820, HPA019887, HPA032101"	Enhanced		Enhanced	Centrosome				Centrosome		"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: "	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	4.7	4.7	16.6	6.9	20.4	12.6	3.6	8.3	16.5	3.2	4.0	4.4	3.8	3.7	3.7	4.1	5.1	3.4	5.0	8.2	12.0	4.2	3.2	4.4	4.3	6.4	7.0	9.7	4.9	3.3	5.9	8.0	3.4	5.6	4.0	4.1	2.0	4.1	4.1	82.3	10.4	4.0	4.2	4.3	5.5	4.6	14.5	9.7	9.1	4.4	2.2	4.8	4.7	5.1	0.4	5.3	4.9	1.2	0.5	10.7	2.3	9.2	7.3	11.3	6.9	5.7	5.8	7.1	7.2	5.0	7.2	6.4	8.8	6.0	9.3	4.6	8.2	6.7	9.1	6.2	5.0	27.0	12.8	24.6	13.6	6.8	1.9	12.4	10.2	3.1	4.7	9.6	4.8	5.5	12.4	14.0	9.8	15.4	12.2	12.8	11.2	5.0	15.2	4.6	8.1	5.6	10.0	13.9	6.2	15.5	9.7	4.7	9.2	9.7	7.5	12.9	6.5	7.3	11.4	12.1	10.1	10.0	8.0	12.2	6.9	4.9	0.8	1.3	2.0	0.6	5.9	0.4	0.9	5.9	2.3	0.2	0.7	10.7	0.5	0.5	1.2	5.3	0.9	2.3	16.6	20.4	8.3	16.5	12.0	4.2	7.0	9.7	5.6	9.7
SDCCAG8	"BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7"	ENSG00000054282	"Serologically defined colon cancer antigen 8"	Q86SQ7	1	243256034-243500092	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025737, HPA044477, HPA072495"	Approved		Enhanced	Centrosome				Centrosome		"HPA025737: , HPA044477: , HPA072495: "	"unprognostic (4.12e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.68e-3)"	"unprognostic (4.69e-2)"	13.5	12.6	17.2	10.0	17.7	7.9	13.0	12.3	17.6	11.4	10.5	22.5	10.4	7.5	13.3	17.7	11.6	17.9	17.6	12.8	16.8	13.5	15.2	7.9	14.8	10.4	17.4	12.0	19.9	17.3	18.0	32.4	11.4	14.2	15.5	8.3	10.7	16.8	13.1	15.1	10.2	9.3	11.3	18.9	15.0	11.0	8.0	20.9	17.4	32.7	7.2	10.4	11.8	10.7	9.8	9.9	9.3	10.7	12.5	8.6	5.2	5.4	4.6	0.7	3.4	5.1	2.9	5.6	3.4	2.9	0.6	1.3	4.5	9.8	2.1	5.7	2.9	1.9	0.6	4.1	1.4	3.5	5.5	1.8	3.4	1.9	3.3	1.7	4.6	6.0	3.9	3.0	6.5	4.2	2.6	3.2	2.5	1.5	0.7	4.3	0.6	7.8	2.8	0.8	1.8	6.1	3.5	4.8	4.8	4.1	2.1	7.8	3.6	2.8	4.2	5.9	1.3	1.8	1.9	4.4	2.2	1.0	2.8	3.8	25.9	9.3	10.7	9.0	6.0	10.5	3.8	7.5	6.4	7.8	9.9	9.8	8.6	6.5	6.9	12.5	5.7	7.9	5.0	5.2	17.2	17.7	12.3	17.6	16.8	13.5	17.4	12.0	14.2	20.9
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176602	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 41.6;testis: 12.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Enhanced	"Microtubules,Mitotic spindle,Centrosome,Cytosol"				Microtubules	"Mitotic spindle, Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.8	0.6	0.6	6.4	0.6	6.2	0.9	0.4	1.6	0.8	2.8	0.3	0.0	1.1	1.0	0.8	5.1	0.2	0.3	0.4	0.8	0.5	0.8	0.5	1.0	6.1	0.6	0.3	0.5	0.4	0.0	0.6	2.6	0.8	0.4	4.0	0.2	0.9	0.0	0.5	2.4	3.1	1.1	0.5	2.6	1.4	12.6	0.3	41.6	0.3	5.7	6.4	0.5	1.4	0.4	0.2	0.3	0.3	1.9	2.3	0.6	11.2	5.9	10.7	9.1	0.0	2.3	8.4	15.2	6.4	19.2	13.1	9.8	12.1	15.4	4.5	8.4	10.6	14.3	6.2	21.0	13.1	7.3	20.5	3.9	5.5	0.0	15.8	7.9	0.4	0.4	15.4	5.1	9.4	10.6	6.6	12.7	8.7	24.0	14.2	12.4	11.1	15.8	23.0	7.1	4.3	4.4	13.7	5.0	5.0	7.9	3.2	7.1	12.2	3.7	7.6	11.0	7.1	18.2	4.0	8.4	15.4	1.8	12.4	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.8	1.4	0.2	0.0	0.8	0.3	0.0	1.9	0.3	0.0	2.3	0.6	0.6	0.6	0.4	1.6	0.8	0.5	0.6	0.3	0.8	0.3
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341322-48426212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol			13000	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: "	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (5.77e-4)"	"prognostic favourable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	14.8	9.3	6.8	11.7	8.6	7.0	12.6	9.2	10.7	18.4	20.7	6.1	11.7	6.9	18.1	12.2	24.0	14.3	12.3	21.3	7.3	5.6	12.8	16.1	14.0	10.6	7.6	7.2	16.4	10.4	17.2	9.4	29.7	8.0	19.0	13.1	14.1	15.2	17.3	49.2	20.1	15.5	30.6	6.2	11.4	13.2	23.6	5.8	23.8	12.1	22.2	16.9	24.9	23.7	7.7	8.5	10.9	8.6	10.7	13.5	4.2	12.6	5.0	9.1	8.9	14.1	17.4	6.4	19.5	25.0	17.6	18.3	4.9	10.7	7.6	12.1	22.4	8.4	37.0	18.4	31.0	6.3	3.8	13.4	7.4	5.6	15.1	12.2	13.7	14.7	27.2	20.3	23.7	10.3	8.5	8.6	17.6	6.4	14.0	10.1	3.8	7.2	8.0	17.7	4.8	15.4	14.0	6.0	7.7	7.9	6.0	8.3	7.5	8.7	13.0	19.3	18.3	12.2	19.9	11.7	12.1	6.5	15.1	14.0	13.8	10.9	8.0	9.6	8.8	5.8	9.9	6.1	11.0	13.5	8.5	7.7	9.1	9.8	7.5	10.7	8.6	2.9	7.1	4.2	6.8	8.6	9.2	10.7	7.3	5.6	7.6	7.2	8.0	5.8
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.3;U-266/70: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome				Centrosome		"HPA034963: , HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favourable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	6.0	20.3	31.4	7.6	34.4	10.3	12.7	8.8	43.1	13.5	8.3	8.1	6.1	5.6	11.7	7.8	6.5	4.7	3.8	5.1	20.6	23.5	1.9	11.1	4.5	8.7	17.1	21.2	12.2	28.4	6.1	10.3	6.0	15.4	9.1	7.8	12.1	5.7	6.9	29.6	15.9	5.1	11.3	5.8	6.3	7.0	7.8	8.5	15.7	5.3	11.5	15.8	5.4	7.8	1.1	8.4	2.0	10.1	5.5	3.9	1.4	3.6	2.8	1.6	8.6	3.7	2.4	2.3	7.0	3.4	2.9	5.0	0.7	0.5	12.0	1.6	10.9	10.6	3.3	0.8	3.0	4.8	1.3	6.2	3.4	7.3	7.9	10.4	5.8	1.1	18.4	3.9	6.1	1.8	4.8	30.3	2.0	3.2	8.8	6.9	1.1	3.4	3.2	0.4	29.7	1.2	1.8	7.3	3.5	4.3	4.0	71.3	4.7	11.5	0.4	4.0	4.8	7.8	4.2	33.3	16.4	29.1	5.9	20.9	21.2	0.0	2.3	2.0	1.0	5.3	1.4	1.1	1.1	1.8	4.4	0.3	0.0	1.0	0.0	5.5	10.1	8.4	3.9	1.4	31.4	34.4	8.8	25.9	20.6	23.5	17.1	21.2	15.4	8.5
TTI2	"C8orf41, FLJ23263"	ENSG00000129696	"TELO2 interacting protein 2"	Q6NXR4	8	33473386-33513601	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023523, HPA029823"	Approved		Enhanced	Centrosome				Centrosome		"HPA023523: AB_1845776, HPA029823: AB_10602337"	"unprognostic (6.30e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.35e-2)"	10.7	13.1	8.0	9.7	12.2	12.0	10.7	11.1	13.5	11.0	9.3	11.2	6.4	8.7	11.8	10.9	11.4	10.5	7.3	12.7	9.4	7.5	10.7	14.0	9.3	14.9	10.1	10.5	10.9	9.9	11.7	16.5	9.2	9.6	9.8	9.5	11.4	12.1	8.7	14.8	11.0	10.5	9.8	10.7	14.3	9.7	25.7	9.0	22.9	13.2	7.6	17.1	10.3	10.2	22.1	36.7	19.3	14.6	17.2	19.3	24.0	5.2	9.8	12.8	12.8	9.4	6.8	5.4	7.9	9.0	13.3	13.3	7.5	4.4	15.0	12.0	5.8	9.3	20.5	9.2	11.9	6.7	6.2	8.9	5.8	8.0	10.6	8.2	9.0	5.5	11.8	9.9	9.0	11.5	13.5	11.9	9.2	10.5	24.6	8.6	17.1	6.5	16.8	10.4	7.1	7.3	5.6	15.7	8.3	7.8	7.2	9.6	7.3	6.7	7.5	8.2	7.3	8.5	7.6	6.5	6.3	22.3	8.2	8.3	8.8	10.4	14.1	19.3	15.7	14.0	16.1	19.2	16.0	15.6	11.9	22.1	19.3	18.1	13.0	17.2	14.6	36.7	15.2	24.0	8.0	12.2	11.1	13.5	9.4	7.5	10.1	10.5	9.6	9.0